Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker–driven learning framework

Current gold standard diagnostic strategies are unable to accurately differentiate malignant from benign small renal masses preoperatively; consequently, 20% of patients undergo unnecessary surgery. Devising a more confident presurgical diagnosis is key to improving treatment decision-making. We the...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Sabrina H., Newsham, Izzy, Pita, Sara, Brennan, Kevin, Park, Gahee, Smith, Christopher G., Lach, Radoslaw P., Mitchell, Thomas, Huang, Junfan, Babbage, Anne, Warren, Anne Y., Leppert, John T., Stewart, Grant D., Gevaert, Olivier, Massie, Charles E., Samarajiwa, Shamith A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519038/
https://www.ncbi.nlm.nih.gov/pubmed/36170366
http://dx.doi.org/10.1126/sciadv.abn9828

Ejemplares similares

Ejemplares similares